(Arg8)-Vasopressin (4-9)

(Arg8)-Vasopressin (4-9) is a modified vasopressin fragment with an arginine substitution at position 8, influencing its interaction with vasopressin receptors. The shortened sequence retains key receptor-binding motifs while offering a more targeted approach for studying vasopressin-mediated signaling. Researchers apply this peptide in studies of fluid homeostasis, blood pressure regulation, and renal function.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: V03007

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C25H44N12O8S
M.W/Mr.
672.77
Sequence
QNCPRG-NH2
Length
6

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide CDMOcGMP Peptide ServicePeptide Modification ServicesPeptide Synthesis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers